Computational Service
Protein Degrader
Scoped After Feasibility Review
Service Overview
Degraders are large, greasy, often poorly soluble molecules with several sites of chemical vulnerability, which makes process development and stability work harder than conventional small molecule CMC. ICDMO supplies the computational layer of that work: retrosynthetic assessment of candidate routes, prediction of likely impurities and degradation pathways, property modelling relevant to formulation, and statistical analysis of process and stability datasets. Manufacture, analytics and GMP operations are performed by your organisation or a qualified partner.
Key Features & Advantages
Route Assessment Before Scale-Up
Candidate routes are compared on step count, convergence, reagent availability and the steps most likely to cause trouble at scale, before process chemistry is committed.
Impurities Predicted, Not Discovered
Likely process impurities and degradation products are predicted from the chemistry and the molecule, so analytical methods can be developed to look for them deliberately.
Degradation Pathways Modelled
Hydrolytic, oxidative and photolytic vulnerabilities are identified structurally, which focuses forced degradation study design on the conditions most likely to be informative.
Data Analysis With Proper Statistics
Process development and stability datasets are analysed with appropriate models, including trend analysis and shelf-life estimation where the data supports it.
Where This Service Is Used
1Comparing candidate synthetic routes before selecting one for development
2Predicting impurities and degradants to guide analytical method development
3Designing forced degradation studies around predicted vulnerabilities
4Analysing process development data, including designed experiments
5Statistical analysis of stability data for shelf-life estimation
How the Work Is Performed
1Retrosynthetic analysis and route comparison with scale-up risk assessment per step
2Impurity prediction from reaction chemistry, reagents and likely side reactions
3Degradation pathway prediction covering hydrolysis, oxidation, photolysis and reactive sites
4Physicochemical modelling relevant to formulation: solubility, logD, ionisation and permeability
5Design of experiments support and statistical analysis of process development datasets
6Stability data analysis with trend assessment and shelf-life estimation where warranted
What We Need From You
1Degrader structure with any route already under consideration
2Process development or stability data to be analysed, with the study design
3Analytical methods in use and any unknown peaks requiring structural hypotheses
4Target product profile and the formulation route intended
What You Receive
1Route assessment comparing candidates with the risks identified per step
2Predicted impurity and degradant structures with the mechanisms behind them
3Forced degradation study design targeting the predicted vulnerabilities
4Property modelling relevant to formulation decisions
5Statistical analysis of process and stability data with figures and interpretation
Questions We Are Asked Before Scoping
Do you manufacture degraders?
▸No. ICDMO is a computational CDMO. We provide route assessment, impurity and degradation prediction and data analysis; synthesis, analytics and GMP manufacture are performed by your organisation or a qualified partner.
Can you identify an unknown peak?
▸We can generate ranked structural hypotheses from the chemistry and the molecule, which is usually enough to direct the analytical work. Confirmation requires MS and NMR data from the laboratory.
Is predicted degradation reliable?
▸It identifies the vulnerable positions well and is genuinely useful for designing forced degradation studies. Which pathway dominates under real conditions is established experimentally.
Interpretation and Limitations
This is a computational (in silico) service. Designs and predictions prioritise hypotheses and direct experimental effort; they do not by themselves establish that an edit, construct, molecule or assay will perform as intended. Laboratory execution — editing, cloning, expression, synthesis and testing — is planned with you and carried out by your own team or a qualified partner. Deliverables are for research use only and are not intended for diagnostic or therapeutic use.
Is This the Right Service for You?
Choose this when
Candidate synthetic routes must be compared before development is committed
Analytical method development needs a prediction of likely impurities
Process or stability data needs statistical analysis and interpretation
Consider another service when
The molecule is still being designed
Protein Degrader Design & Synthesis Metabolic rather than chemical stability is the concern
Metabolic Stability & CYP Prediction What Goes Wrong, and How We Handle It
These are the failure modes that produce confident-looking results which do not survive the next experiment. Each one is designed against rather than discovered afterwards.
Impurities discovered during scale-up rather than anticipated
Likely process impurities and degradants are predicted from the chemistry so methods can be developed to look for them deliberately.
Forced degradation studies designed without a hypothesis
Structural vulnerability analysis focuses the study on conditions most likely to be informative.
Stability trends read off plots without statistics
Trend analysis and shelf-life estimation are performed with appropriate models, and stated as unsupported where the data is too sparse.
A Worked Example
Predicting an unknown peak before it appeared
The situation
An unidentified impurity grew during stability testing and the analytical team had no structural hypothesis.
What the work involved
Degradation pathways were predicted across hydrolytic, oxidative and photolytic conditions, candidate structures were generated, and predicted fragmentation was compared against the observed mass data.
What came back
Three ranked structural hypotheses, one of which matched the fragmentation pattern. The forced degradation study was redesigned around the implicated linkage.
Illustrative of the shape this work takes. Details are generalised, no client or target is identified, and scope and outcome vary with the system in question.
Service Workflow
1
Scientific Consultation
We discuss the objective, the decision it supports and the material and data you already hold.
2
Feasibility Review
We check that the target, system and available information can support the approach, and say plainly where they cannot.
3
Technical Proposal
Scope, methods, deliverables, timeline and price are confirmed in writing, together with the limitations we expect to report.
4
Design and Analysis
The design work runs on documented tools and parameters, with quality checks and alternatives compared where that is informative.
5
Delivery and Follow-Up
You receive the designs, the supporting analysis and a validation plan, plus support interpreting the results once the experiments run.
Service Process
1
Online Consultation
›
2
Solution Matching
›
3
Service Contract
›
4
Project Execution
›
5
Data Delivery
Specifications & Turnaround
Note: ICDMO delivers computational (in silico) services. Results prioritise hypotheses for testing; they do not by themselves establish binding, biological activity, efficacy or safety. All deliverables are for research use only and are not intended for diagnostic or therapeutic use. Downstream experimental work is scoped separately and executed through qualified partners.
Get a Custom Quote
Our scientific team responds within 24 hours with a detailed technical proposal and pricing tailored to your project.
Contact Us Online ConsultationStandard Deliverables
✓Sequence-verified final product
✓Full QC documentation
✓Certificate of Analysis (CoA)
✓Electronic data files
✓Project completion report
Why ICDMO?
Computational CDMO Focus
Reproducible, Versioned Pipelines
Confidence & Limitations Reported
Experiment-Aware Recommendations
Response Within One Business Day